Business Description

Description
BioAdaptives Inc is engaged in investigating, marketing and distributing natural plant- and algal-based products and medical devices that improve health and wellness for humans and animals, with an emphasis on pain relief, anti-viral function, and anti-aging properties. Its products include dietary supplements using natural ingredients and proprietary methods of optimizing the availability of nutrients in foods and beverages. The human products are designed to aid memory, cognition and focus; assist in sleep and fatigue reduction; provide pain relief and healing; and improve overall emotional and physical wellness. Its product lines include PluriPain, PrimiLungs, SleepEZ, MindNMemory, Cell Rejuven and ProteinNMore.

Financial Strength

Name Current Vs Industry Vs History
Cash-To-Debt 0.19
Equity-to-Asset -15.84
Debt-to-Equity -0.2
Debt-to-EBITDA -0.63
Piotroski F-Score 4/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score -147.39
Distress
Grey
Safe
Beneish M-Score -8.82
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC

Growth Rank

Name Current Vs Industry Vs History
3-Year EBITDA Growth Rate 67.8
3-Year EPS without NRI Growth Rate 64.3
3-Year Book Growth Rate 68.8

Momentum Rank

Name Current Vs Industry Vs History
5-Day RSI 49.95
9-Day RSI 48.16
14-Day RSI 48.02
6-1 Month Momentum % -63.64
12-1 Month Momentum % -42.86

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 0.05
Quick Ratio 0.04
Cash Ratio 0.03
Days Inventory 180.35
Days Sales Outstanding 39.11
Days Payable 77.29

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -250.3
Shareholder Yield % 14.57

Profitability Rank

Name Current Vs Industry Vs History
Gross Margin % 39.29
Operating Margin % -817.86
Net Margin % -2542.86
FCF Margin % -796.43
ROA % -670.43
ROIC % -18.6

GF Value Rank

Name Current Vs Industry Vs History
PE Ratio without NRI N/A
N/A
N/A
EV-to-EBIT -1.29
EV-to-EBITDA -1.36
EV-to-Revenue 25.21
EV-to-FCF -3.56
Earnings Yield (Greenblatt) % -77.52
FCF Yield % -45.88

Financials

BDPT's 30-Y Financials
Income Statement Breakdown
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with OTCPK:BDPT

No Available Data

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

BioAdaptives Inc Executives

Details

GF Value

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 0.028
EPS (TTM) ($) -0.001
Beta 0.93
Volatility % 309.87
14-Day RSI 48.02
14-Day ATR ($) 0.000152
20-Day SMA ($) 0.000551
12-1 Month Momentum % -42.86
52-Week Range ($) 0.00025 - 0.006
Shares Outstanding (Mil) 972.16

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 4
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

BioAdaptives Inc Filings

Filing Date Document Date Form
No Filing Data

BioAdaptives Inc Stock Events

Financials Calendars
Event Date Price($)
No Event Data

BioAdaptives Inc Frequently Asked Questions

What is BioAdaptives Inc(BDPT)'s stock price today?
The current price of BDPT is $0.00. The 52 week high of BDPT is $0.01 and 52 week low is $0.00.
When is next earnings date of BioAdaptives Inc(BDPT)?
The next earnings date of BioAdaptives Inc(BDPT) is .
Does BioAdaptives Inc(BDPT) pay dividends? If so, how much?
BioAdaptives Inc(BDPT) does not pay dividend.

Press Release

Subject Date
No Press Release

Headlines

See More
  • 1
No news.
  • 1